Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Historical perspective on movement disorders.

Joseph H Friedman1

  • 1Brown University Medical School and the Division of Neurology, Memorial Hospital of Rhode Island, Pawtucket, RI 02860, USA. joseph_friedman@mhri.org

The Journal of Clinical Psychiatry
|June 11, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Longitudinal Dynamics of Polyglutamine-Expanded ATXN3 in Biofluids of Spinocerebellar Ataxia Type 3.

Movement disorders : official journal of the Movement Disorder Society·2026
Same author

Delayed Onset of Neurological Symptoms in Carbon Monoxide Poisoning.

Rhode Island medical journal (2013)·2026
Same author

True vignettes: interesting, illustrative examples of behavioral abnormalities in people with Parkinson's disease.

Arquivos de neuro-psiquiatria·2026
Same author

Why "change in management" is a poor measure for DaT scan usefulness.

Parkinsonism & related disorders·2026
Same author

Functional Disorders.

Rhode Island medical journal (2013)·2026
Same author

Publication Bias.

Rhode Island medical journal (2013)·2025

Traditional antipsychotics caused movement disorders like tardive dyskinesia. Atypical antipsychotics significantly reduced these involuntary movements, suggesting they are not an inherent part of schizophrenia.

Area of Science:

  • Neuroscience
  • Psychiatry
  • Pharmacology

Background:

  • Antipsychotic medications, particularly older neuroleptics, were associated with significant risks of movement disorders.
  • Tardive dyskinesia, a potentially irreversible adverse effect, was a major concern for physicians treating psychosis.

Observation:

  • Historical accounts and modern studies of neuroleptic-naïve schizophrenia patients reveal distinct movement patterns.
  • Early researchers noted differences in movement disorders between treated and untreated schizophrenia patients.

Findings:

  • The development of atypical antipsychotics has led to a marked decrease in the incidence and prevalence of tardive dyskinesia.
  • Evidence suggests that movement disorders are not an intrinsic feature of schizophrenia itself.

Related Experiment Videos

Implications:

  • Psychosis, antipsychotic treatment, and the development of dyskinesias are not necessarily interconnected.
  • Understanding the relationship between medication and movement disorders is crucial for refining schizophrenia treatment strategies.